Sponsor or institution
Clinical trials and research at R-Pharm
As of November 12, 2026, Find a Trial lists 4 clinical trials run by R-Pharm that are recruiting, at sites in 3 countries (most in Russia (4), Armenia (1), Turkey (Türkiye) (1)). By phase: Phase 2 (2), Phase 2/3 (1), Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 3Countries
Newest trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| RPH-030 versus Vectibix with FOLFIRI for first-line treatment of RAS wild-type metastatic colorectal cancer | Phase 1 | Arkhangelsk and 25 other locations | Recruiting | Apr 22, 2026 |
| Olokizumab treatment for children with polyarticular juvenile idiopathic arthritis | Phase 2 | Kazan' and 13 other locations | Recruiting | Apr 8, 2026 |
| Evaluating Olokizumab for Progressive Fibrosing Lung Diseases | Phase 2/3 | Barnaul and 32 other locations | Recruiting | Jun 4, 2024 |
| Using RPH-104 to prevent fever attacks in patients with Familial Mediterranean Fever who can't tolerate colchicine | Phase 2 | Yerevan and 7 other locations | Recruiting | Jan 13, 2022 |
All recruiting trials (4)
-
RPH-030 versus Vectibix with FOLFIRI for first-line treatment of RAS wild-type metastatic colorectal cancer
This trial will test whether RPH-030 works like Vectibix when given with FOLFIRI as first-line treatment for people with metastatic colorectal cancer who have RAS wild-type tumors.
-
Olokizumab treatment for children with polyarticular juvenile idiopathic arthritis
This test gives weight-based doses of olokizumab every 4 weeks to see if it helps control polyarticular juvenile idiopathic arthritis and is safe for children aged 2–17.
-
Evaluating Olokizumab for Progressive Fibrosing Lung Diseases
This study is testing if a new injection called olokizumab can help people with progressive fibrosing lung diseases breathe better and improve their overall health compared to a placebo.
-
Using RPH-104 to prevent fever attacks in patients with Familial Mediterranean Fever who can't tolerate colchicine
This study is testing if RPH-104 can help adults with Familial Mediterranean Fever who can’t take colchicine by preventing their fever attacks over a long period.
Quick answers
How many clinical trials run by R-Pharm are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 3 countries. The most sites are in Russia (4 trials), Armenia (1 trial), Turkey (Türkiye) (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 2, Phase 2/3: 1, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.